Ontology highlight
ABSTRACT: Aims
To evaluate the efficacy and safety of the PROMETA™ Protocol for treating methamphetamine dependence.Design
A double-blind, placebo-controlled 108-day study with random assignment to one of two study conditions: active medication with flumazenil (2 mg infusions on days 1, 2, 3, 22, 23), gabapentin (1200 mg to day 40) and hydroxazine (50 mg to day 10) versus placebo medication (with active hydroxazine only).Setting
Three substance abuse treatment clinics: two in-patient, one out-patient.Participants
Treatment-seeking, methamphetamine-dependent adults (n = 120).Measurements
Primary outcome was percentage of urine samples testing negative for methamphetamine during the trial.Findings
No statistically significant between-group differences we
SUBMITTER: Ling W
PROVIDER: S-EPMC4122522 | biostudies-literature | 2012 Feb
REPOSITORIES: biostudies-literature